EUVIMEDEUVIMED entdecken
Crossref

2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis

Maëva Pichon iD, Fabienne Levi-Acobas, Camélia Kitoun, Marcel Hollenstein iD

Chemistry – A European Journal · 25.04.2024 · 30 (24)

DOI: 10.1002/chem.202400137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 13.03.2024. Verfasst von Maëva Pichon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, CNRS UMR3523, Department of Structural Biology and Chemistry, Laboratory for Bioorganic Chemistry of Nucleic…. Hauptthemen laut MEDLINE: RNA, DNA-Directed RNA Polymerases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Institut Pasteur, Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Besides being a key player in numerous fundamental biological processes, RNA also represents a versatile platform for the creation of therapeutic agents and efficient vaccines. The production of RNA oligonucleotides, especially those decorated with chemical modifications, cannot meet the exponential demand. Due to the inherent limits of solid‐phase synthesis and in vitro transcription, alternative, biocatalytic approaches are in dire need to facilitate the production of RNA oligonucleotides. Here, we present a first step towards the controlled enzymatic synthesis of RNA oligonucleotides. We have explored the possibility of a simple protection step of the vicinal cis‐diol moiety to temporarily block ribonucleotides. We demonstrate that pyrimidine nucleotides protected with acetals, particularly 2′,3′‐ O ‐isopropylidene, are well‐tolerated by the template‐independent RNA polymerase PUP (polyU polymerase) and highly efficient coupling reactions can be achieved within minutes – an important feature for the development of enzymatic de novo synthesis protocols. Even though purines are not equally well‐tolerated, these findings clearly demonstrate the possibility of using cis ‐diol‐protected ribonucleotides combined with template‐independent polymerases for the stepwise construction of RNA oligonucleotides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNADNA-Directed RNA PolymerasesOligonucleotidesRibonucleotidesNucleotidesPyrimidine Nucleotides

Stichwörter der Autor:innen

RNAcontrolled enzymatic synthesisde novo RNA synthesismodified nucleotidespolymerases

Substanzen

RNADNA-Directed RNA PolymerasesOligonucleotidesRibonucleotidesNucleotidesPyrimidine Nucleotides

Autor:innen und Institutionen

  • Institut Pasteur, Université Paris Cité, CNRS UMR3523, Department of Structural Biology and Chemistry, Laboratory for Bioorganic Chemistry of Nucleic Acids, 28, rue du Docteur Roux, 75724, Paris Cedex 15, France.

ORCID-Profile: Maëva Pichon, Marcel Hollenstein

Förderung

  • Institut Pasteur
  • Sanofi

Zitieren

APA

Pichon, M., Levi-Acobas, F., Kitoun, C., & Hollenstein, M. (2024). 2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis. Chemistry – A European Journal, 30(24). https://doi.org/10.1002/chem.202400137

Vancouver

Pichon M, Levi-Acobas F, Kitoun C, Hollenstein M. 2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis. Chemistry – A European Journal. 2024;30(24). doi:10.1002/chem.202400137

BibTeX
@article{Pichon2024,
  author = {Pichon, Maëva and Levi-Acobas, Fabienne and Kitoun, Camélia and Hollenstein, Marcel},
  title = {2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis},
  journal = {Chemistry – A European Journal},
  year = {2024},
  volume = {30},
  number = {24},
  doi = {10.1002/chem.202400137}
}
Kostenlos starten →